未登录First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists A Cost-Effectiveness Study
Choi, Jin G.; Winn, Aaron N.; Skandari, M. Reza; Franco, Melissa, I; Staab, Erin M.; Alexander, Jason; Wan, Wen; Zhu, Mengqi; Huang, Elbert S.; Philipson, Louis; Laiteerapong, Neda
分享
收藏
分享
收藏Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis
Alexander, Jason T.; Staab, Erin M.; Wan, Wen; Franco, Melissa; Knitter, Alexandra; Skandari, M. Reza; Bolen, Shari; Maruthur, Nisa M.; Huang, Elbert S.; Philipson, Louis H.; Winn, Aaron N.; Thomas, Celeste C.; Zeytinoglu, Meltem; Press, Valerie G.; Tung, Elizabeth L.; Gunter, Kathryn; Bindon, Brittany; Jumani, Sanjay; Laiteerapong, Neda
分享
收藏The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis胰高血糖素样肽-1受体激动剂的长期益处和危害: 系统评价和荟萃分析
Alexander, Jason T.; Staab, Erin M.; Wan, Wen; Franco, Melissa; Knitter, Alexandra; Skandari, M. Reza; Bolen, Shari; Maruthur, Nisa M.; Huang, Elbert S.; Philipson, Louis H.; Winn, Aaron N.; Thomas, Celeste C.; Zeytinoglu, Meltem; Press, Valerie G.; Tung, Elizabeth L.; Gunter, Kathryn; Bindon, Brittany; Jumani, Sanjay; Laiteerapong, Neda
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏